CAR- T and mobile gene therapies are as well expensive

.Nature Medicine, Released online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care manufacturing and technology transfer can easily deliver cell gene treatments at an affordable expense to patients across the planet.